Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for B-lymphoblastic leukemia with ZNF384 rearrangement has been reported in the published literature.
No clinical trials have been registered for B-lymphoblastic leukemia with ZNF384 rearrangement.
2 publications have been identified in PubMed for B-lymphoblastic leukemia with ZNF384 rearrangement. Research spans Diagnostic / Biomarker (50%) and Case Report / Case Series (50%).
Li Q (2025). [PMID: 39520726](https://pubmed.ncbi.nlm.nih.gov/39520726/). *Leukemia & lymphoma*. [Diagnostic / Biomarker]
Srinivasan T (2024). [PMID: 39469177](https://pubmed.ncbi.nlm.nih.gov/39469177/). *Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:50 AM UTC
Common questions about B-lymphoblastic leukemia with ZNF384 rearrangement